Elicio Therapeutics, Inc. (ELTX) stock
ELTXNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.43−0.05 (-3.38%)
Close on Nov 17, 2026Market cap $37.58MP/E –Yield –
Elicio Therapeutics price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Elicio Therapeutics's price to book ratio was 4.5× on Nov 11, 2026, against 93.4× a year earlier. Over the last 3 years it ranged from 0.1× to 141.3×, with a median of 5.3×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 4.5× | −31.5 |
| 2025 | Dec 31, 2025 | 36.0× | +25.1 |
| 2024 | Jul 31, 2024 | 10.9× | +5.6 |
| 2023 | Dec 29, 2023 | 5.3× | +5.1 |
| 2022 | Jan 31, 2022 | 0.1× | −0.0 |
| 2021 | Dec 31, 2021 | 0.1× | – |
See a number that looks wrong?